Altesa BioSciences has appointed Brett Haumann as CEO
ARS Pharmaceuticals co-founder Richard Lowenthal is stepping down as CEO, with the company’s president, Donn Casale replacing him
Bicara Therapeutics CEO, Claire Mazumdar, Ph.D., is stepping down. COO Ryan Cohlhepp will step into the role of CEO beginning January 1
BioNTech has appointed Guido Oelkers, Ph.D., as CEO
ElevaraMedicines has appointed Mai-Britt Zocca as CEO, replacing Emma Tinsley
Helus Pharma has appointed Michael Halstead as CEO
Illuminare Biotechnologies has appointed Brian Longstreet as CEO
Juvena Therapeutics has appointed Julie Anne Smith as CEO
Legend Biotech CEO Ying Huang, Ph.D., is now CEO of K2 Therapeutics
Longevica Therapeutics has named Prasun Mishra as CEO
Nasus Pharma has appointed Brendan O’Grady as CEO
Neumora Therapeutics has appointed Joshua Pinto, Ph.D., as CEO
NovaBridge BioSciences has appointed Srishti Gupta, M.D., as CEO
MBX Biosciences’ co-founder and CEO Kent Hawryluk stepped down from the company and its board. Executive board chairman Steve Hoerter has stepped in as CEO
Mentari Therapeutics has appointed Greg Divis as CEO
Sarepta Therapeutics has appointed Michael Severino, M.D., as CEO
Tanai Therapeutics has appointed Josua Jordi, Ph.D., as CEO